Exploring Pull Mechanisms to encourage Neglected Disease R&D in the EU

This study examines innovative funding mechanisms to help the European Union (EU) fund global health innovation, including advance market commitments, and others. It was developed in consultation with over 30 leading organisations from academia, industry, and civil society. It includes case studies of successful incentives implemented to drive research and development (R&D) in areas of unmet medical need, such as neglected, rare, or emerging infectious diseases.